Cargando…

A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants

Large-scale populations in the world have been vaccinated with COVID-19 vaccines, however, breakthrough infections of SARS-CoV-2 are still growing rapidly due to the emergence of immune-evasive variants, especially Omicron. It is urgent to develop effective broad-spectrum vaccines to better control...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jing, Han, Zi Bo, Liang, Yu, Zhang, Xue Feng, Jin, Yu Qin, Du, Li Fang, Shao, Shuai, Wang, Hui, Hou, Jun Wei, Xu, Ke, Lei, Wenwen, Lei, Ze Hua, Liu, Zhao Ming, Zhang, Jin, Hou, Ya Nan, Liu, Ning, Shen, Fu Jie, Wu, Jin Juan, Zheng, Xiang, Li, Xin Yu, Li, Xin, Huang, Wei Jin, Wu, Gui Zhen, Su, Ji Guo, Li, Qi Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2022
Materias:	Immunology and Inflammation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481243/ https://www.ncbi.nlm.nih.gov/pubmed/36004719 http://dx.doi.org/10.7554/eLife.78633

Ejemplares similares

Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2
por: Liang, Yu, et al.
Publicado: (2022)

Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies
por: Ai, Yuanbao, et al.
Publicado: (2022)

A potent human neutralizing antibody Fc-dependently reduces established HBV infections
por: Li, Dan, et al.
Publicado: (2017)

Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial
por: Kaabi, Nawal Al, et al.
Publicado: (2023)

High-resolution mapping of the neutralizing and binding specificities of polyclonal sera post-HIV Env trimer vaccination
por: Dingens, Adam S, et al.
Publicado: (2021)

Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo
por: Li, Mengjiao, et al.
Publicado: (2022)

LncRNA NEAT1 promotes malignant phenotypes and TMZ resistance in glioblastoma stem cells by regulating let-7g-5p/MAP3K1 axis
por: Bi, Chang-Long, et al.
Publicado: (2020)

A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD
por: Wang, Xiaofei, et al.
Publicado: (2022)

Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study
por: Shao, Miao, et al.
Publicado: (2022)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody
por: Yin, Wanchao, et al.
Publicado: (2022)

Fingerprinting trimeric SARS-CoV-2 RBD by capillary isoelectric focusing with whole-column imaging detection
por: Du, Jialiang, et al.
Publicado: (2023)

An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
por: Luo, Deyan, et al.
Publicado: (2022)

ACLY ubiquitination by CUL3-KLHL25 induces the reprogramming of fatty acid metabolism to facilitate iTreg differentiation
por: Tian, Miaomiao, et al.
Publicado: (2021)

Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2
por: Xu, Kun, et al.
Publicado: (2022)

A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
por: Yuan, Mengqi, et al.
Publicado: (2022)

Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7
por: Zhang, Yanfang, et al.
Publicado: (2023)

Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD
por: Li, Yulei, et al.
Publicado: (2023)

Exosomes derived from LPS-stimulated human thymic mesenchymal stromal cells enhance inflammation via thrombospondin-1
por: Li, Qianru, et al.
Publicado: (2021)

Reversible promoter methylation determines fluctuating expression of acute phase proteins
por: Zhang, Shi-Chao, et al.
Publicado: (2020)

MicroRNAs of the miR-17~92 family maintain adipose tissue macrophage homeostasis by sustaining IL-10 expression
por: Zhang, Xiang, et al.
Publicado: (2020)

Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding
por: Lin, Sheng, et al.
Publicado: (2022)

Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein
por: Chen, Yu-Lei, et al.
Publicado: (2022)

Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
por: Fan, Chengcheng, et al.
Publicado: (2022)

Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2
por: Lei, Hong, et al.
Publicado: (2020)

Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD
por: Li, Qianqian, et al.
Publicado: (2022)

NAD(+) attenuates experimental autoimmune encephalomyelitis through induction of CD11b(+) gr-1(+) myeloid-derived suppressor cells
por: Wang, Jin-Li, et al.
Publicado: (2020)

MR1-restricted T cells: the new dawn of cancer immunotherapy
por: Wang, Zhiding, et al.
Publicado: (2020)

Atmospheric particulate matter aggravates CNS demyelination through involvement of TLR-4/NF-kB signaling and microglial activation
por: Han, Bing, et al.
Publicado: (2022)

E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies
por: Wang, Wei Bu, et al.
Publicado: (2021)

Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
por: Ma, Hang, et al.
Publicado: (2022)

Mutated trimeric RBD vaccines: a platform against variants of concern
por: Aparicio, Belén, et al.
Publicado: (2023)

MicroRNA-543-3p down-regulates inflammation and inhibits periodontitis through KLF6
por: Li, Wei, et al.
Publicado: (2021)

An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant
por: Yuan, Mengqi, et al.
Publicado: (2023)

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
por: Li, Tao, et al.
Publicado: (2023)

MicroRNA-223 decreases cell proliferation, migration, invasion, and enhances cell apoptosis in childhood acute lymphoblastic leukemia via targeting Forkhead box O 1
por: Li, Chunyu, et al.
Publicado: (2020)

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant
por: He, Cai, et al.
Publicado: (2022)

Potent neutralizing RBD‐specific antibody cocktail against SARS‐CoV‐2 and its mutant
por: Jia, Lina, et al.
Publicado: (2021)

T follicular helper 17 (Tfh17) cells are superior for immunological memory maintenance
por: Gao, Xin, et al.
Publicado: (2023)

RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants
por: Liang, Qingtai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j7fmg98p53fc2g4jobu4l9um0g